Calcivis Closes Final Tranche of £4.5M Equity Funding

Calcivis, a UK-based medical devices company specializing in tooth decay management and preventive dentistry, has secured the final tranche of its £4.5 million equity funding round. Led by Archangels, with support from the Scottish Investment Bank, the funds will be used to support Calcivis' development as it anticipates FDA approval for its CALCIVIS® Imaging System in the US. The company plans to launch its system in the US in 2020, pending approval. Calcivis' imaging system provides dentists with visual evidence of early-stage demineralization, allowing them to differentiate between active and inactive lesions. Since its inception, Calcivis has raised over £14 million in equity and grant funding.

Calcivis Closes Final Tranche of £4.5 Million Equity Funding

Calcivis is a medical devices company headquartered in Edinburgh, Scotland, UK, focused on managing tooth decay and enabling preventive dentistry. The company develops and markets the CALCIVIS® Imaging System, which provides dentists with visual evidence of demineralization at an early stage, allowing for accurate monitoring of tooth enamel conditions.

Calcivis is a medical devices company focused on managing tooth decay and enabling preventive dentistry.

6 years ago

Calcivis Closes Final Tranche of £4.5 Million Equity Funding

ProblemHealthcare

Solution

Covered on